CST3 and multiple sclerosis: Cystatin C undergoes proteolytic processing, and a 12.5 kDa cleavage product was reported to be elevated in the CSF of patients suffering from multiple sclerosis, even if the levels of full-length 13.4 kDa cystatin C were unaltered [31].